Newsenselab spots seven-figure round

Newsenselab, a Germany-based migraine treatment app spinout from Humboldt University of Berlin, today raised a seven-figure sum in a follow-on round backed by public-private partnership High-Tech Gründerfonds (HTGF) and Think.Health Ventures.
Following the round, Think.Health Ventures has become Newsenselab’s principal investor.
Spun out in 2016 from Humboldt’s department of physics, Newsenselab has developed a digital health app called M-sense that helps tackle migraine and headache outbreaks by using big data analytics to evaluate potential triggers.
M-Sense classifies whether the problem relates to a migraine or tension headache. It utilises a patient diary detailing environmental, lifestyle and hormonal factors to suggest what might be causing recurrent episodes.
Newsenselab will use the capital to add features including personalised prevention strategies and therapies to the app, which currently has approximately 80,000 users. Additional cash will support Newsenselab’s efforts to enter new markets.
HTGF and Think.Health Ventures had already backed Newsenselab in November 2016 as part of a six-figure round that also featured Flying Health and an unnamed angel investor, both of which had provided the spinout with capital earlier that same year.
Newsenselab was co-founded by chief executive Stefan Greiner, who had previously studied human-computer interaction at Technical University of Berlin.
Greiner said: “With M-sense, we are offering a unique digital treatment plan for migraine patients. We are now expanding this service and tapping new markets.”